IP Library › Granted Patent US 8,969,013
Granted Patent B2
US 8,969,013 · App. 13/748,507 · Granted Mar 3, 2015

Method for identifying lineage-related antibodies

Inventor: Guo-Liang Yu (Hillsborough, CA)
Assignee: EPITOMICS, Inc.
G01N33/577C07K16/00C07K16/2863C07K2317/10C07K2317/56C07K2317/76G01N33/6854G01N33/566
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,969,013
App. No.
13/748,507
Granted
Mar 3, 2015
Kind
B2
Abstract

In certain embodiments, the method may comprise: a) obtaining the antibody sequences from a population of B cells; b) grouping the antibody sequences to provide a plurality of groups of lineage-related antibodies; c) testing a single antibody from each of the groups in a bioassay and, after the first antibody has been identified, d) testing further antibodies that are in the same group as the first antibody in a second bioassay. In another embodiment, the method may comprise: a) testing a plurality of antibodies obtained from a first portion of an antibody producing organ of an animal; b) obtaining the sequence of a first identified antibody; c) obtaining from a second portion of said antibody producing organ the sequences of further antibodies that are related by lineage to said first antibody; and, c) testing the further antibodies in a second bioassay.

Claims (17)

1. A method comprising:

a) obtaining antibody heavy chain sequences and antibody light chain sequences from a population of B cells of an animal, wherein said population of B cells comprises B cells that produce antibodies that specifically bind to a target antigen;

b) grouping the antibodies based on their lineage to provide a plurality of groups of antibodies, wherein the antibodies in each group have heavy chain CDR3 regions that have 0, 1 or 2 amino acid substitutions relative to one another and light chain CDR3 regions that have 0, 1 or 2 amino acid substitutions relative to one another;

c) testing a single antibody from each group of a plurality of the groups of b) in a first assay to identify a first antibody that has an activity; and, after said first antibody has been identified:

d) testing a further antibody that is in the same group as the first antibody in a second assay, thereby identifying a second antibody that has said activity.

2. The method of claim 1 , wherein step a) comprises obtaining at least 1,000 heavy chain sequences and at least 1,000 light chain sequences from said population of B cells.

3. The method of claim 1 , wherein said population of B cells is enriched by affinity for a substrate comprising said target antigen.

4. The method of claim 1 , wherein each of said groups of antibodies comprises at least two members.

5. The method of claim 1 , wherein said single antibody from each of said groups comprises naturally paired heavy chain and light chain variable domains.

6. The method of claim 1 , wherein said single antibody from each of said groups comprises non-naturally paired heavy chain and light chain variable domains.

7. The method of claim 1 , wherein said further antibodies comprise naturally paired heavy and light chain variable domains.

8. The method of claim 1 , wherein said further antibodies comprise non-naturally paired heavy and light chain variable domains.

9. The method of claim 1 , wherein said first and second assays are the same.

10. The method of claim 1 , wherein said first and second assays are selected from the group consisting of a blocking assay and a neutralization assay.

11. The method of claim 1 , wherein said animal is immunized with said antigen prior to said obtaining step a).

12. The method of claim 1 , wherein the animal is a rabbit.

13. The method of claim 1 , wherein the antibodies within each of said groups are related to one another by lineage and comprise heavy chain CDR3 regions that have 0 amino acid substitutions relative to one another and light chain CDR3 regions that have 0 amino acid substitutions relative to one another.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2013
From: YU, GUO-LIANG
To: EPITOMICS, INC.
Reel/Frame 030072/0462 →
Continuity (4)
Continuation 13552517 · Jul 18, 2012
Continuation 12878925 · Sep 9, 2010
Provisional Application 61241714 · Sep 11, 2009
Related Publication 20130130932A1 · May 23, 2013